Roman Liebe

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

TGF-β serves as a critical signaling determinant of liver progenitor cell activation and function.

TGF-β serves as a critical signaling determinant of liver progenitor cell activation and function.

Journal: The Journal of clinical investigation

Published: July 28, 2026

Use of genetic analysis in adult cholestatic liver disease: lessons from progressive paediatric syndromes and cohort studies.

Use of genetic analysis in adult cholestatic liver disease: lessons from progressive paediatric syndromes and cohort studies.

Journal: Gut

Published: November 07, 2025

Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.

Erratum: Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure.

Journal: Hepatology (Baltimore, Md.)

Published: November 03, 2025

Prolonged Intrahepatic Cholestasis After Acute Hepatitis E Infection: A Case Series and Genetic Analysis.

Prolonged Intrahepatic Cholestasis After Acute Hepatitis E Infection: A Case Series and Genetic Analysis.

Journal: Journal of viral hepatitis

Published: October 08, 2025

Massive hepatic necrosis-associated acute liver failure.

Massive hepatic necrosis-associated acute liver failure.

Journal: eGastroenterology

Published: March 27, 2025

ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling.

ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling.

Journal: JHEP reports : innovation in hepatology

Published: January 08, 2025

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation.

ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation.

Journal: Gut

Published: June 25, 2024

The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.

The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects.

Journal: Biochemical and biophysical research communications

Published: May 24, 2024

Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure.

Retinoic acid generates a beneficial microenvironment for liver progenitor cell activation in acute liver failure.

Journal: Hepatology communications

Published: January 23, 2024

ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.

ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.

Journal: Journal of hepatology

Published: October 31, 2023

Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge.

Dysbiosis and nutrition in steatotic liver disease: addressing the unrecognized small intestinal bacterial overgrowth (SIBO) challenge.

Journal: Internal and emergency medicine

Published: September 25, 2023

The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation.

The Interplay of TGF-β1 and Cholesterol Orchestrating Hepatocyte Cell Fate, EMT, and Signals for HSC Activation.

Journal: Cellular and molecular gastroenterology and hepatology

Published: August 22, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026